Alprazolam
- Product NDC
- 0228-2039
- 11-digit product format
- 002282039
- Labeler code
- 0228
- Product ID
- 0228-2039_9cf12473-8eb9-4248-bfce-76eef6b82bfd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alprazolam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA074342
- Marketing category
- ANDA
- Marketing start
- 1993-10-01
- Substance
- ALPRAZOLAM
- Active strength
- 2 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Alprazolam
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALPRAZOLAM | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | YU55MQ3IZY |
| Rxcui | 197321, 197322, 308047, 308048 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0228-2039-10 | Alprazolam | 100 in 1 BOTTLE | TABLET | 100 | | 22 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ALPRAZOLAM | ACTIVE INGREDIENT | YU55MQ3IZY | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 8 | |
| ALPRAZOLAM | ACTIVE MOIETY | YU55MQ3IZY | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 8 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 8 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 8 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 8 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 8 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 8 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 8 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 8 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 8 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 8 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 8 | |
| ALPRAZOLAM | ACTIVE INGREDIENT | YU55MQ3IZY | ALPRAZOLAM TABLET [MEDSOURCE PHARMACEUTICALS] | 2 | |
| ALPRAZOLAM | ACTIVE MOIETY | YU55MQ3IZY | ALPRAZOLAM TABLET [MEDSOURCE PHARMACEUTICALS] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ALPRAZOLAM TABLET [MEDSOURCE PHARMACEUTICALS] | 2 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | ALPRAZOLAM TABLET [MEDSOURCE PHARMACEUTICALS] | 2 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM TABLET [MEDSOURCE PHARMACEUTICALS] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ALPRAZOLAM TABLET [MEDSOURCE PHARMACEUTICALS] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ALPRAZOLAM TABLET [MEDSOURCE PHARMACEUTICALS] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ALPRAZOLAM TABLET [MEDSOURCE PHARMACEUTICALS] | 2 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | ALPRAZOLAM TABLET [MEDSOURCE PHARMACEUTICALS] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ALPRAZOLAM TABLET [MEDSOURCE PHARMACEUTICALS] | 2 | |
| ALPRAZOLAM | ACTIVE INGREDIENT | YU55MQ3IZY | ALPRAZOLAM TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| ALPRAZOLAM | ACTIVE MOIETY | YU55MQ3IZY | ALPRAZOLAM TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ALPRAZOLAM TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | ALPRAZOLAM TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | ALPRAZOLAM TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | ALPRAZOLAM TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | ALPRAZOLAM TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ALPRAZOLAM TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ALPRAZOLAM TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | ALPRAZOLAM TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ALPRAZOLAM TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0228-2039 | ALPRAZOLAM TABLET [ACTAVIS PHARMA, INC.] | 21 | Current NDC, Legacy NDC, 1 package rows | 20250116_a23063c0-099a-4256-b95f-3a857bbf704b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0228-2039-10 | 00228203910 | 100 TABLET in 1 BOTTLE (0228-2039-10) | 100 tablet | 1993-10-01 | 0000-00-00 | No | No | Current |